Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 174 (LINC00174) is a long noncoding RNA located on human chromosome 7 and belongs to the family of antisense lncRNAs[5]. LINC00174 does not code for a protein but regulates the expression of other genes through interaction with microRNAs, acting as a competitive endogenous RNA (ceRNA). It is abnormally expressed in several cancers, including glioma, non-small cell lung cancer, colorectal cancer, and thymic epithelial tumors, where it impacts key cellular processes such as proliferation, migration, invasion, apoptosis, and glycolysis[1][2][4][6]. Mechanistically, LINC00174 functions by sponging specific microRNAs (including miR-31-5p and miR-152-3p), thereby regulating the expression of downstream target genes such as LATS2 and SLC2A1[1][2]. Its dysregulation in tumor tissues and correlation with prognosis make it a candidate biomarker and a potential molecular therapeutic target, although no direct drug interactions are currently known.
Competitive endogenous RNA sponging of microRNAs (e.g., miR-31-5p, miR-152-3p); Upregulation of tumor suppressor or oncogene transcripts via miRNA sequestration
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 174 (LINC00174).